Page 3 - Martin Pierre Laurent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2023

Lyon, France - 21 December 2022 - 6:00pm CET - Theranexus, an innovative biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug

France generalThierry lambertFlorence portejoieMartin pierre laurentAtomic energy commissionEnd resultsFrench alternative energiesEuronext growth

THERANEXUS ANNOUNCES PARTICIPATION IN THE 41ST ANNUAL J P MORGAN HEALTHCARE CONFERENCE JANUARY 9-12, 2023 IN SAN FRANCISCO

THERANEXUS ANNOUNCES PARTICIPATION IN THE 41ST ANNUAL J P MORGAN HEALTHCARE CONFERENCE JANUARY 9-12, 2023 IN SAN FRANCISCO
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalSan franciscoThierry lambertMartin pierre laurentFlorence portejoieNeuroscience innovation forum onAtomic energy commissionHealthcare conferenceBiotech showcaseSachs associateAnnual neuroscience innovation forumFrench alternative energiesEuronext growth

THERANEXUS AND BBDF PRESENT PROGRESS ON THE BATTEN-1 PROGRAM AT THE TRANSLATIONAL RESEARCH CONFERENCE FOR THE MANAGEMENT OF NCLS ON 3 AND 4 NOVEMBER, 2022 IN CHICAGO

Lyon, France - Austin, Texas, United States - 2 November 2022 - 6pm CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalThierry lambertMathieu charvFlorence portejoieMartin pierre laurentEmyr lloyd evansCardiff university school of biosciencesNational organization for rare disordersTranslational research conference for the managementAtomic energy commissionBatten disease foundationBeyond batten disease foundationCardiff universityTranslational research conferenceCardiff university school

THERANEXUS: THERANEXUS ANNOUNCES ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2022

Lyon, France - 27 September 2022 - 6pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating

France generalThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonResearch tax creditAtomic energy commissionIris capitalFrench alternative energiesEuronext growth

THERANEXUS: Theranexus and BBDF finalize recruitment for phase I/II trial to evaluate Batten-1 in Batten disease

Lyon, France - Austin, Texas, United States - 8 September 2022 - 6 pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalGary clarkCraig bensonThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonNational organization for rare disordersAtomic energy commissionBatten disease foundationBeyond batten disease foundationChild neurologyTexas childrenFrench alternative energiesEuronext growth